Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05626491 · ClinicalTrials.gov registry record · NA

Electrical Stimulation for the Treatment of Glaucoma

A NA study of Glaucoma and Glaucoma Open-Angle, sponsored by Stanford University.

Recruiting
Registry status
NA
Development phase
45
Enrollment target
4
Study locations

NCT05626491 is a NA study of Glaucoma and Glaucoma Open-Angle that is actively recruiting participants, run by Stanford University. The registered enrollment target is 45 participants, below the 910-participant average among 92 other Glaucoma trials with a reported enrollment target (95% lower). The trial reports 4 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05626491, a NA study of Glaucoma and Glaucoma Open-Angle, is actively recruiting participants, sponsored by Stanford University.

RECRUITING
Registry status
NA
Development phase
45 participants
Enrollment target
4
Study locations

Study Summary

The overall aim of this study is to see whether long-term electrical stimulation with a home-stimulation device works well and is safe for the treatment of open-angle glaucoma. Open-Angle Glaucoma is a disease where the nerves in the back of your eye die off faster than expected regardless of your eye pressure.

Conditions Studied

Glaucoma Glaucoma Open-Angle

Interventions

  • DEVICE Repetitive, Transorbital Alternating Current Stimulation (rtACS)
  • DEVICE Sham Repetitive, Transorbital Alternating Current Stimulation (rtACS)

Study Locations (4)

California

  • Byers Eye Institute - Palo Alto

New York

  • NYU- Langone - New York

Pennsylvania

  • Wills Eye Hospital - Philadelphia

Other

  • Otto-von-Guericke University - Magdeburg

Trial Details

FieldValue
Enrollment Target 45 participants
Start Date 2023-02-28
Est. Completion 2025-12
Phase NA

Sponsor

Stanford University

1,744 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05626491

The ClinicalTrials.gov registry entry for NCT05626491 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 910-participant average among 92 other Glaucoma trials with a reported enrollment target (95% lower). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Glaucoma appearing as the primary indexed condition, and to 2 interventions - of which Repetitive, Transorbital Alternating Current Stimulation (rtACS) is the first listed.

NCT05626491 reports 4 study locations spanning 4 distinct geographic areas - top geographies include California, New York, Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT05626491 about?

NCT05626491 is a clinical study titled "Electrical Stimulation for the Treatment of Glaucoma". The overall aim of this study is to see whether long-term electrical stimulation with a home-stimulation device works well and is safe for the treatment of open-angle glaucoma. Open-Angle Glaucoma is a disease where the nerves in the back of your eye die off faster than expected regardless of your e...

What is the current status of trial NCT05626491?

This trial is currently recruiting. It is a NA study. The enrollment target is 45 participants. The study started on 2023-02-28. Estimated completion is 2025-12.

What conditions does trial NCT05626491 study?

This clinical trial studies the following conditions: Glaucoma, Glaucoma Open-Angle.

What interventions are being tested in trial NCT05626491?

The interventions under investigation include: Repetitive, Transorbital Alternating Current Stimulation (rtACS) (DEVICE), Sham Repetitive, Transorbital Alternating Current Stimulation (rtACS) (DEVICE).

Who is sponsoring clinical trial NCT05626491?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05626491 being conducted?

This trial has 4 study locations across California, New York, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Glaucoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Glaucoma

All registered trials for this condition

Glaucoma Open-Angle

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.